These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25118239)

  • 1. Glycan degradation (GlyDeR) analysis predicts mammalian gut microbiota abundance and host diet-specific adaptations.
    Eilam O; Zarecki R; Oberhardt M; Ursell LK; Kupiec M; Knight R; Gophna U; Ruppin E
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan utilisation system in Bacteroides and Bifidobacteria and their roles in gut stability and health.
    Singh RP
    Appl Microbiol Biotechnol; 2019 Sep; 103(18):7287-7315. PubMed ID: 31332487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease.
    Cockburn DW; Koropatkin NM
    J Mol Biol; 2016 Aug; 428(16):3230-3252. PubMed ID: 27393306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal Prioritization to Dietary Glycans by Gut Bacteria in a Competitive Environment Promotes Stable Coexistence.
    Tuncil YE; Xiao Y; Porter NT; Reuhs BL; Martens EC; Hamaker BR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communal living: glycan utilization by the human gut microbiota.
    Briggs JA; Grondin JM; Brumer H
    Environ Microbiol; 2021 Jan; 23(1):15-35. PubMed ID: 33185970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota functional activity biosensors for characterizing nutrient metabolism in vivo.
    Wesener DA; Beller ZW; Peters SL; Rajabi A; Dimartino G; Giannone RJ; Hettich RL; Gordon JI
    Elife; 2021 Mar; 10():. PubMed ID: 33684031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How glycan metabolism shapes the human gut microbiota.
    Koropatkin NM; Cameron EA; Martens EC
    Nat Rev Microbiol; 2012 Apr; 10(5):323-35. PubMed ID: 22491358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The devil lies in the details: how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes.
    Martens EC; Kelly AG; Tauzin AS; Brumer H
    J Mol Biol; 2014 Nov; 426(23):3851-65. PubMed ID: 25026064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics Approaches To Decipher the Impact of Diet and Host Physiology on the Mammalian Gut Microbiome.
    Milani C; Alessandri G; Mancabelli L; Mangifesta M; Lugli GA; Viappiani A; Longhi G; Anzalone R; Duranti S; Turroni F; Ossiprandi MC; van Sinderen D; Ventura M
    Appl Environ Microbiol; 2020 Nov; 86(23):. PubMed ID: 32948523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying glycan consumers in human gut microbiota samples using metabolic labeling coupled with fluorescence-activated cell sorting.
    Dridi L; Altamura F; Gonzalez E; Lui O; Kubinski R; Pidgeon R; Montagut A; Chong J; Xia J; Maurice CF; Castagner B
    Nat Commun; 2023 Feb; 14(1):662. PubMed ID: 36750571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compendium of 5810 genomes of sheep and goat gut microbiomes provides new insights into the glycan and mucin utilization.
    Zhang K; He C; Wang L; Suo L; Guo M; Guo J; Zhang T; Xu Y; Lei Y; Liu G; Qian Q; Mao Y; Kalds P; Wu Y; Cuoji A; Yang Y; Brugger D; Gan S; Wang M; Wang X; Zhao F; Chen Y
    Microbiome; 2024 Jun; 12(1):104. PubMed ID: 38845047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host Mucosal Glycans.
    Pudlo NA; Urs K; Kumar SS; German JB; Mills DA; Martens EC
    mBio; 2015 Nov; 6(6):e01282-15. PubMed ID: 26556271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan Utilization and Cross-Feeding Activities by Bifidobacteria.
    Turroni F; Milani C; Duranti S; Mahony J; van Sinderen D; Ventura M
    Trends Microbiol; 2018 Apr; 26(4):339-350. PubMed ID: 29089173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing future prebiotic fiber to target metabolic syndrome.
    Jakobsdottir G; Nyman M; Fåk F
    Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal glycan degradation of the host by the gut microbiota.
    Bell A; Juge N
    Glycobiology; 2021 Jun; 31(6):691-696. PubMed ID: 33043970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metage2Metabo, microbiota-scale metabolic complementarity for the identification of key species.
    Belcour A; Frioux C; Aite M; Bretaudeau A; Hildebrand F; Siegel A
    Elife; 2020 Dec; 9():. PubMed ID: 33372654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin glycans and their degradation by gut microbiota.
    Yamaguchi M; Yamamoto K
    Glycoconj J; 2023 Aug; 40(4):493-512. PubMed ID: 37318672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating the Gut Microbiota of Humans by Dietary Intervention with Plant Glycans.
    Tannock GW
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33355114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals.
    Ormerod KL; Wood DL; Lachner N; Gellatly SL; Daly JN; Parsons JD; Dal'Molin CG; Palfreyman RW; Nielsen LK; Cooper MA; Morrison M; Hansbro PM; Hugenholtz P
    Microbiome; 2016 Jul; 4(1):36. PubMed ID: 27388460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micronutrient Requirements and Sharing Capabilities of the Human Gut Microbiome.
    Rodionov DA; Arzamasov AA; Khoroshkin MS; Iablokov SN; Leyn SA; Peterson SN; Novichkov PS; Osterman AL
    Front Microbiol; 2019; 10():1316. PubMed ID: 31275260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.